MedTrace Logo

Analysis of Screen-detected Lung Cancers' Genomic Traits

NCT04204499 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 526

Last updated 2026-05-14

No results posted yet for this study

Summary

Prospective, observational cohort study of patients undergoing surgical resection for low dose CT (LDCT) screen-detected lung cancer (detected through the SUMMIT study- ClinicalTrials.gov Identifier: NCT03934866/ lung screening programmes), in which translational research is a fundamental aspect.

Conditions

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Sam Janes · UCL

Eligibility

Min Age
50 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04204499 on ClinicalTrials.gov